Stat5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells

Oncogene

Volumn 24, Issue 5, 2005, Pages 746-760

  Sultan, Ahmed S ^a   Xie, Jianwu ^a   LeBaron, Matthew J ^a   Ealley, Erica L ^a   Nevalainen, Marja T ^a   Rui, Hallgeir ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Adhesion; Breast cancer; E cadherin; Invasion; Metastasis; Stat5

Indexed keywords

BETA CATENIN; MATRIGEL; MATRIX METALLOPROTEINASE; PROLACTIN; STAT5 PROTEIN; TUMOR MARKER; UVOMORULIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL KINETICS; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE ACTIVATION; GENETIC STABILITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CADHERINS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; MICE; MILK PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; PROLACTIN; RECOMBINANT PROTEINS; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION;

EID: 13444263403     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208203     Document Type: Article

References (58)

1. Acosta JJ, Munoz RM, Gonzalez L, Subtil-Rodriguez A, Dominguez-Caceres MA, Garcia-Martinez JM, Calcabrini A, Lazaro-Trueba I and Martin-Perez J. (2003). Mol. Endocrinol., 17, 2268-2282.
2. Ahonen TJ, Xie J, LeBaron MJ, Zhu J, Nurmi M, Alanen K, Rui H and Nevalainen MT. (2003). J. Biol. Chem., 278, 27287-27292.
3. Albini A, Allavena G, Melchiori A, Giancotti F, Richter H, Comoglio PM, Parodi S, Martin GR and Tarone G. (1987). J. Cell Biol., 105, 1867-1872.
4. Arihiro K, Oda H, Kaneko M and Inai K. (2000). Breast Cancer, 7, 221-230.
5. Badache A and Hynes NE. (2001). Cancer Res., 61, 383-391.
6. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R and Birchmeier W. (1996). Nature, 382, 638-642.
7. Benitah SA, Valeron PF, Rui H and Lacal JC. (2003). Mol. Biol. Cell, 14, 40-53.
8. Berx G and Van Roy F. (2001). Breast Cancer Res., 3, 289-293.
9. Bukholm IK, Nesland JM, Karesen R, Jacobsen U and Borresen-Dale AL. (1998). J. Pathol., 185, 262-266.
10. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, Akira S, Clarke AR and Watson CJ. (1999). Genes Dev., 13, 2604-2616.
11. Clevenger CV, Furth PA, Hankinson SE and Schuler LA. (2003). Endocr. Rev., 24, 1-27.
12. Cotarla I, Ren S, Zhang Y, Gehan E, Singh B and Furth PA. (2004). Int. J. Cancer, 108, 665-671.
13. Coussens LM and Werb Z. (1996). Chem. Biol., 3, 895-904.
14. Das R and Vonderhaar BK. (1996). Oncogene, 13, 1139-1145.
15. Duhe RJ, Rui H, Greenwood JD, Garvey K and Farrar WL. (1995). Gene, 158, 281-285.
16. Erwin RA, Kirken RA, Malabarba MG, Farrar WL and Rui H. (1995). Endocrinology, 136, 3512-3518.
17. Fearon ER. (2003). Cancer Cell, 3, 307-310.
18. Gouilleux F, Wakao H, Mundt M and Groner B. (1994). EMBO J., 13, 4361-4369.
19. Grimley PM, Dong F and Rui H. (1999). Cytokine Growth Factor Rev., 10, 131-157.
20. Groner B and Hennighausen L. (2000). Breast Cancer Res., 2, 149-153.
21. Humphreys RC and Hennighausen L. (1999). Cell Growth Differ., 10, 685-694.
22. Iavnilovitch E, Groner B and Barash I. (2002). Mol. Cancer Res., 1, 32-47.
23. Kabotyanski EB and Rosen JM. (2003). J. Biol. Chem., 278, 17218-17227.
24. Kazansky AV, Raught B, Lindsey SM, Wang YF and Rosen JM. (1995). Mol. Endocrinol., 9, 1598-1609.
25. Kemler R and Ozawa M. (1989). BioEssays, 11, 88-91.
26. Kim J, Yu W, Kovalski K and Ossowski L. (1998). Cell, 94, 353-362.
27. Kinch MS, Clark GJ, Der CJ and Burridge K. (1995). J. Cell Biol., 130, 461-471.
28. Le TL, Yap AS and Stow JL. (1999). J. Cell Biol., 146, 219-232.
29. Lilien J, Balsamo J, Arregui C and Xu G. (2002). Dev. Dyn., 224, 18-29.
30. Liu X, Gallego MI, Smith GH, Robinson GW and Hennighausen L. (1998). Cell Growth Differ., 9, 795-803.
31. Liu X, Robinson GW, Gouilleux F, Groner B and Hennighausen L. (1995). Proc. Natl. Acad. Sci. USA, 92, 8831-8835.
32. Liu X, Robinson GW and Hennighausen L. (1996). Mol. Endocrinol., 10, 1496-1506.
33. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A and Hennighausen L. (1997). Genes Dev., 11, 179-186.
34. Marte BM, Jeschke M, Graus-Porta D, Taverna D, Hofer P, Groner B, Yarden Y and Hynes NE. (1995). Mol. Endocrinol., 9, 14-23.
35. Maus MV, Reilly SC and Clevenger CV. (1999). Endocrinology, 140, 5447-5450.
36. Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR and Yoneda T. (1996). Cancer Res., 56, 4063-4070.
37. Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KU, Oka T, Rosen JM, Robinson GW and Hennighausen L. (2001). J. Cell Biol., 155, 531-542.
38. Nevalainen MT, Xie J, Bubendorf L, Wagner KU and Rui H. (2002). Mol. Endocrinol., 16, 1108-1124.
39. Nevalainen MT, Xie J, Torhorst J, Bubendorf L, Haas P, Kononen J, Sauter G and Rui H. (2004). J. Clin. Oncol., 22, 2053-2060.
40. Papkoff J. (1997). J. Biol. Chem., 272, 4536-4543.
41. Paterson AD, Parton RG, Ferguson C, Stow JL and Yap AS. (2003). J. Biol. Chem., 278, 21050-21057.
42. Philips N and McFadden K. (2004). Cancer Lett., 206, 63-68.
43. Ren S, Cai HR, Li M and Furth PA. (2002). Oncogene, 21, 4335-4339.
44. Schaber JD, Fang H, Xu J, Grimley PM and Rui H. (1998). Cancer Res., 58, 1914-1919.
45. Schmidhauser C, Casperson GF, Myers CA, Sanzo KT, Bolten S and Bissell MJ. (1992). Mol. Biol. Cell, 3, 699-709.
46. Shiu RP and Paterson JA. (1984). Cancer Res., 44, 1178-1186.
47. Stockinger A, Eger A, Wolf J, Beug H and Foisner R. (2001). J. Cell Biol., 154, 1185-1196.
48. Sultan AS, Miyoshi E, Ihara Y, Nishikawa A, Tsukada Y and Taniguchi N. (1997). J. Biol. Chem., 272, 2866-2872.
49. Teglund S, McKay C, Schuetz E, van Deursen JM, Stravopodis D, Wang D, Brown M, Bodner S, Grosveld G and Ihle JN. (1998). Cell, 93, 841-850.
50. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ and Davey HW. (1997). Proc. Natl. Acad. Sci. USA, 94, 7239-7244.
51. Wagner K-U, Krempler A, Triplett AA, Qi Y, George NM, Zhu J and Rui H. (2004). Mol. Cell Biol., 24, 5510-5520.
52. Wakao H, Gouilleux F and Groner B. (1994). EMBO J., 13, 2182-2191.
53. Wheelock MJ and Johnson KR. (2003). Annu. Rev. Cell Dev. Biol., 19, 207-235.
54. Xie J, LeBaron MJ, Nevalainen MT and Rui H. (2002). J. Biol. Chem., 277, 14020-14030.
55. Yamashita H, Iwase H, Toyama T and Fujii Y. (2003). Oncogene, 22, 1638-1652.
56. Yamashita H, Xu J, Erwin RA, Larner AC and Rui H. (1999). J. Biol. Chem., 274, 14699-14705.
57. Yasumitsu H, Miyazaki K, Umenishi F, Koshikawa N and Umeda M. (1992). J. Biochem. (Tokyo), 111, 74-80.
58. Zhang S, Herrmann C and Grosse F. (1999). J. Cell Sci., 112 (Part 16), 2693-2703.